ABC Affiliate, KSTP Channel 5 News Features Physeon’s Efforts to Improve Patient Care with the VIVA Trial
Physeon GmbH, a leading developer of medical technology products for venous access, announced that its Veinplicity® Device was featured on a segment produced by ABC affiliate KSTP Channel 5.
The segment can be viewed found by going to the following link: Video
Physeon’s Chief Executive Officer Patrick Kullmann stated “I’d like to thank ABC News KSTP Channel 5’s Leah McLane for the feature on our Veinplicity Device. This feature comes on the heels of a recent growing list of good news including our recent announcement that the Mayo Clinic and Gregory Schears, M.D., were selected as a trial site and principal investigator for Physeon’s “VIVA” (Veinplicity for Improved Venous Access) trial in the United States, and that previously announced positive results from our first clinical trial were published in highly respected Journal of Vascular Access.”